These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12967783)

  • 1. Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells.
    Ichim TE; Zhong R; Min WP
    Transpl Immunol; 2003; 11(3-4):295-306. PubMed ID: 12967783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
    Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
    Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections.
    Kusuhara M; Matsue H
    Exp Dermatol; 2005 Apr; 14(4):273-80. PubMed ID: 15810885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells.
    Lott DG; Dan O; Lu L; Strome M
    Laryngoscope; 2010 Jan; 120(1):44-52. PubMed ID: 19877191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of rapamycin in the induction of tolerogenic dendritic cells.
    Fischer R; Turnquist HR; Taner T; Thomson AW
    Handb Exp Pharmacol; 2009; (188):215-32. PubMed ID: 19031028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of therapeutic dendritic cells and regulatory T cells for preventing allogeneic cardiac graft rejection.
    Zhang X; Li M; Lian D; Zheng X; Zhang ZX; Ichim TE; Xia X; Huang X; Vladau C; Suzuki M; Garcia B; Jevnikar AM; Min WP
    Clin Immunol; 2008 Jun; 127(3):313-21. PubMed ID: 18358783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.
    Roelen DL; Schuurhuis DH; van den Boogaardt DE; Koekkoek K; van Miert PP; van Schip JJ; Laban S; Rea D; Melief CJ; Offringa R; Ossendorp F; Claas FH
    Transplantation; 2003 Dec; 76(11):1608-15. PubMed ID: 14702533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive dendritic cells as a tool for controlling allograft rejection in organ transplantation: promises and difficulties.
    Ehser S; Chuang JJ; Kleist C; Sandra-Petrescu F; Iancu M; Wang D; Opelz G; Terness P
    Hum Immunol; 2008 Mar; 69(3):165-73. PubMed ID: 18396208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of acute and chronic allograft rejection by combinations of tolerogenic dendritic cells.
    Huang YL; Wang YZ; Chen JB; Wang F; Kang XP; Xia JJ; Lan TS; Xie BY; Ekberg H; Wang XM; Qi ZQ
    Scand J Immunol; 2011 Feb; 73(2):91-101. PubMed ID: 21198749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-specific tolerance induced by IL-10 gene modified immature dendritic cells in experimental autoimmune myocarditis in rats.
    Li WM; Liu W; Gao C; Zhou BG; Yang SS; Wang Z; Zhang RH; Gan RT; Kong YH; Li Y
    Chin Med J (Engl); 2006 Oct; 119(19):1646-52. PubMed ID: 17042978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of tolerogenic dendritic cells for transplantation.
    Morelli AE; Hackstein H; Thomson AW
    Semin Immunol; 2001 Oct; 13(5):323-35. PubMed ID: 11502167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation.
    Turnquist HR; Thomson AW
    Curr Opin Organ Transplant; 2008 Aug; 13(4):350-7. PubMed ID: 18685329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells.
    Cools N; Ponsaerts P; Van Tendeloo VF; Berneman ZN
    J Leukoc Biol; 2007 Dec; 82(6):1365-74. PubMed ID: 17711977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
    Zahorchak AF; Kean LS; Tokita D; Turnquist HR; Abe M; Finke J; Hamby K; Rigby MR; Larsen CP; Thomson AW
    Transplantation; 2007 Jul; 84(2):196-206. PubMed ID: 17667811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The innate natural killer cells in transplant rejection and tolerance induction.
    Kroemer A; Edtinger K; Li XC
    Curr Opin Organ Transplant; 2008 Aug; 13(4):339-43. PubMed ID: 18685327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of type 1 diabetes by immature dendritic cells treated with an ethanol extract of Paecilomyces hepiali Chen mycelium.
    Zhang C; Zou X; Leluo G; Xu J; Xiang M
    Methods Find Exp Clin Pharmacol; 2008; 30(6):421-9. PubMed ID: 18850043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune tolerance induced by adoptive transfer of dendritic cells in an insulin-dependent diabetes mellitus murine model.
    Zhang CL; Zou XL; Peng JB; Xiang M
    Acta Pharmacol Sin; 2007 Jan; 28(1):98-104. PubMed ID: 17184588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance.
    Kim YS; Yang SH; Kang HG; Seong EY; Lee SH; Gao W; Kenny J; Zheng XX; Strom TB
    Int Immunol; 2006 Dec; 18(12):1771-7. PubMed ID: 17068105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.